Senomyx, Inc. is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries. The Company operates through development and commercialization of flavor ingredients segment. It is engaged in the discovery, development and/or commercialization of flavor ingredients through over five programs. The Sweet Taste Program is focused on developing flavor ingredients or discovering natural sweeteners. The Savory Flavor Program is focused at flavor ingredients to be used in product categories, such as ready meals, sauces, soups and snack foods. The Bitter Blocker Program is focused on flavor ingredients used in products that contain bitter tastants. The Cooling Taste Program is focused at flavor ingredients used in products that consist of cooling agents. The salt taste modifier program is focused on reduction of the level of salt contained in packaged food and beverage products.
Industry, Sector and Symbol:
- Sector: Consumer Staples
- Industry: Biotechnology & Medical Research - NEC
- Sub-Industry: N/A
- Symbol: NASDAQ:SNMX
- CUSIP: N/A
- Web: www.senomyx.com
Capitalization:- Market Cap: $28.51 million
- Outstanding Shares: 47,514,000
Average Prices:- 50 Day Moving Avg: $0.74
- 200 Day Moving Avg: $0.92
- 52 Week Range: $0.56 - $4.85
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -3.33
- P/E Growth: -0.04
Sales & Book Value:- Annual Revenue: $19.56 million
- Price / Sales: 1.46
- Book Value: $0.26 per share
- Price / Book: 2.31
Profitability:- EBIDTA: ($11,720,000.00)
- Net Margins: -63.38%
- Return on Equity: -85.22%
- Return on Assets: -54.58%
Debt:- Current Ratio: 3.74%
- Quick Ratio: 3.29%
Misc:- Average Volume: 154,461 shs.
- Beta: 0.99
- Short Ratio: 13.84
Frequently Asked Questions for Senomyx (NASDAQ:SNMX)
What is Senomyx's stock symbol?
Senomyx trades on the NASDAQ under the ticker symbol "SNMX."
How were Senomyx's earnings last quarter?
Senomyx, Inc. (NASDAQ:SNMX) announced its quarterly earnings results on Thursday, July, 27th. The company reported ($0.06) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.07) by $0.01. The firm had revenue of $4.87 million for the quarter, compared to analysts' expectations of $4.60 million. Senomyx had a negative return on equity of 85.22% and a negative net margin of 63.38%. The company's revenue was down 25.8% on a year-over-year basis. During the same period in the prior year, the business posted ($0.05) earnings per share. View Senomyx's Earnings History.
When will Senomyx make its next earnings announcement?
Where is Senomyx's stock going? Where will Senomyx's stock price be in 2017?
3 analysts have issued 12 month price objectives for Senomyx's shares. Their predictions range from $2.00 to $2.00. On average, they anticipate Senomyx's share price to reach $2.00 in the next twelve months. View Analyst Ratings for Senomyx.
Who are some of Senomyx's key competitors?
Some companies that are related to Senomyx include OvaScience (OVAS), Infinity Pharmaceuticals (INFI), Sunesis Pharmaceuticals (SNSS), Fibrocell Science (FCSC), Prima BioMed Ltd (PBMD), Aptose Biosciences (APTO), Cleveland BioLabs (CBLI), AEterna Zentaris (AEZS), Bio-Path Holdings (BPTH), Scancell Holdings Plc (SCLP), Burcon NutraScience Corp (BUR), Oncobiologics (ONS), Prana Biotechnology Ltd (PRAN), OncoSec Medical Incorporated (ONCS), Oxford Pharmascience Group Plc (OXP), Novogen Limited (NVGN), RXi Pharmaceuticals Corporation (RXII) and OpGen (OPGN).
Who are Senomyx's key executives?
Senomyx's management team includes the folowing people:
- Kent Snyder, Chairman of the Board
- John W. Poyhonen, President, Chief Executive Officer, Director
- Antony E. Rogers, Chief Financial Officer, Senior Vice President
- Sharon Wicker, Senior Vice President, Chief Commercial Development Officer
- David Humphrey, Vice President - Finance
- Daniel Edward Stebbins, Director
- Stephen A. Block Esq., Independent Director
- Mary Ann Gray Ph.D., Independent Director
- Michael E. Herman, Independent Director
- Christopher J. Twomey, Independent Director
Who owns Senomyx stock?
Senomyx's stock is owned by many different of retail and institutional investors. Top institutional investors include Senvest Management LLC (13.37%), Lagoda Investment Management L.P. (4.32%), Vanguard Group Inc. (3.03%), Cowen Prime Services LLC (0.74%), Algert Global LLC (0.66%) and Prescott Group Capital Management L.L.C. (0.58%). Company insiders that own Senomyx stock include John Poyhonen and Mary Ann Gray. View Institutional Ownership Trends for Senomyx.
Who sold Senomyx stock? Who is selling Senomyx stock?
Who bought Senomyx stock? Who is buying Senomyx stock?
Senomyx's stock was acquired by a variety of institutional investors in the last quarter, including Cowen Prime Services LLC. Company insiders that have bought Senomyx stock in the last two years include John Poyhonen and Mary Ann Gray. View Insider Buying and Selling for Senomyx.
How do I buy Senomyx stock?
Shares of Senomyx can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Senomyx's stock price today?
One share of Senomyx stock can currently be purchased for approximately $0.60.
MarketBeat Community Rating for Senomyx (NASDAQ SNMX)MarketBeat's community ratings are surveys of what our community members think about Senomyx and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for Senomyx (NASDAQ:SNMX)Earnings History by Quarter for Senomyx (NASDAQ SNMX)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/25/2017 | | | | | | | N/A |  |
| 7/27/2017 | Q2 2017 | ($0.07) | ($0.06) | $4.60 million | $4.87 million | View | N/A | |
| 4/28/2017 | Q1 2017 | ($0.08) | ($0.07) | $4.22 million | $4.47 million | View | N/A | |
| 3/2/2017 | Q4 2016 | ($0.09) | ($0.08) | $4.30 million | $4.20 million | View | Listen | |
| 10/27/2016 | Q316 | ($0.07) | ($0.05) | $5.36 million | $6.00 million | View | Listen | |
| 7/28/2016 | Q2 | ($0.06) | ($0.05) | $6.20 million | $6.60 million | View | Listen | |
| 4/28/2016 | Q1 | ($0.08) | ($0.05) | $5.78 million | $6.30 million | View | Listen | |
| 3/3/2016 | Q4 | ($0.07) | ($0.07) | $6.97 million | $6.27 million | View | Listen | |
| 10/29/2015 | Q315 | ($0.06) | ($0.05) | $7.62 million | $7.40 million | View | Listen | |
| 7/30/2015 | Q215 | ($0.10) | ($0.06) | $6.13 million | $6.20 million | View | Listen | |
| 4/30/2015 | Q115 | ($0.10) | ($0.11) | $5.86 million | $5.00 million | View | Listen | |
| 2/26/2015 | Q414 | ($0.11) | ($0.07) | $6.60 million | $6.30 million | View | Listen | |
| 11/6/2014 | Q314 | ($0.08) | ($0.10) | $7.90 million | $5.90 million | View | Listen | |
| 7/31/2014 | Q214 | ($0.08) | ($0.06) | $7.46 million | $7.34 million | View | Listen | |
| 5/1/2014 | Q114 | ($0.07) | ($0.05) | $7.60 million | $8.20 million | View | Listen | |
| 3/13/2014 | Q413 | ($0.06) | ($0.08) | $7.82 million | $7.41 million | View | Listen | |
| 11/12/2013 | Q313 | ($0.05) | ($0.09) | $8.19 million | $6.70 million | View | Listen | |
| 8/1/2013 | Q2 2013 | ($0.06) | ($0.06) | $7.64 million | $7.70 million | View | Listen | |
| 4/25/2013 | Q1 2013 | ($0.04) | ($0.07) | $8.45 million | $7.48 million | View | Listen | |
| 3/15/2013 | Q4 2012 | ($0.04) | ($0.06) | $8.39 million | $6.73 million | View | Listen | |
| 11/8/2012 | Q312 | ($0.07) | ($0.05) | $7.66 million | $7.90 million | View | N/A | |
| 8/7/2012 | | ($0.08) | ($0.08) | | | View | N/A | |
| 5/3/2012 | | ($0.05) | ($0.05) | | | View | N/A | |
| 3/1/2012 | | ($0.05) | ($0.04) | | | View | N/A | |
| 10/27/2011 | | ($0.08) | ($0.07) | | | View | N/A | |
| 8/5/2011 | | ($0.09) | ($0.08) | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Senomyx (NASDAQ:SNMX)2017 EPS Consensus Estimate: ($0.25)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | ($0.07) | ($0.07) | ($0.07) |
| Q2 2017 | 1 | ($0.07) | ($0.07) | ($0.07) |
| Q3 2017 | 1 | ($0.06) | ($0.06) | ($0.06) |
| Q4 2017 | 1 | ($0.05) | ($0.05) | ($0.05) |
(Data provided by Zacks Investment Research)
Dividend History for Senomyx (NASDAQ:SNMX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Senomyx (NASDAQ:SNMX)Insider Ownership Percentage: 12.40%
Institutional Ownership Percentage: 31.16%
Insider Trades by Quarter for Senomyx (NASDAQ:SNMX)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 3/24/2017 | Mary Ann Gray | Director | Buy | 10,000 | $1.00 | $10,000.00 | |
| 3/23/2017 | John Poyhonen | CEO | Buy | 50,000 | $0.98 | $49,000.00 | |
| 3/11/2015 | Sharon Wicker | SVP | Buy | 20,000 | $4.33 | $86,600.00 | |
| 10/1/2014 | Jay M Phd Short | Director | Sell | 7,500 | $8.16 | $61,200.00 | |
| 9/17/2014 | Donald Karanewsky | VP | Sell | 20,000 | $8.61 | $172,200.00 | |
| 9/11/2014 | Sharon Wicker | SVP | Sell | 40,525 | $9.12 | $369,588.00 | |
| 9/10/2014 | Antony E Rogers | CFO | Sell | 14,800 | $9.00 | $133,200.00 | |
| 9/10/2014 | Donald Karanewsky | VP | Sell | 20,000 | $8.50 | $170,000.00 | |
| 9/10/2014 | Sharon Wicker | SVP | Sell | 21,988 | $9.00 | $197,892.00 | |
| 6/19/2014 | Donald Karanewsky | VP | Sell | 20,000 | $8.86 | $177,200.00 | |
| 6/19/2014 | Sharon Wicker | SVP | Sell | 50,100 | $9.12 | $456,912.00 | |
| 6/13/2014 | Antony E Rogers | CFO | Sell | 2,997 | $8.41 | $25,204.77 | |
| 6/12/2014 | Donald Karanewsky | VP | Sell | 20,000 | $8.50 | $170,000.00 | |
| 6/10/2014 | Stephen A Block | Director | Sell | 28,750 | $8.21 | $236,037.50 | |
| 6/5/2014 | John Poyhonen | CEO | Sell | 37,600 | $8.00 | $300,800.00 | |
| 5/9/2014 | Michael E Herman | Director | Buy | 14,000 | $6.47 | $90,580.00 | |
| 4/17/2014 | Donald Karanewsky | VP | Sell | 20,000 | $8.72 | $174,400.00 | |
| 4/11/2014 | Kent Snyder | Director | Sell | 45,688 | $9.88 | $451,397.44 | |
| 4/9/2014 | Kent Snyder | Director | Sell | 45,688 | $10.60 | $484,292.80 | |
| 4/7/2014 | Kent Snyder | Director | Sell | 68,532 | $11.13 | $762,761.16 | |
| 4/7/2014 | Sharon Wicker | SVP | Sell | 31,154 | $10.61 | $330,543.94 | |
| 4/2/2014 | Kent Snyder | Director | Sell | 68,532 | $11.06 | $757,963.92 | |
| 4/1/2014 | Jay M Phd Short | Director | Sell | 11,590 | $10.66 | $123,549.40 | |
| 3/17/2014 | Michael E Herman | Director | Buy | 33,000 | $10.09 | $332,970.00 | |
| 1/14/2014 | Jay M Phd Short | Director | Sell | 4,090 | $6.50 | $26,585.00 | |
| 12/23/2013 | Sharon Wicker | SVP | Sell | 13,749 | $4.80 | $65,995.20 | |
| 12/20/2013 | Sharon Wicker | SVP | Sell | 38,565 | $4.71 | $181,641.15 | |
| 12/3/2013 | Sharon Wicker | SVP | Sell | 91,196 | $4.24 | $386,671.04 | |
| 11/25/2013 | Sharon Wicker | SVP | Sell | 12,269 | $4.21 | $51,652.49 | |
(Data available from 1/1/2013 forward)
Headline Trends for Senomyx (NASDAQ:SNMX)
Latest Headlines for Senomyx (NASDAQ:SNMX)
| Source: |
|
| Date | Headline |
|---|
 | ETFs with exposure to Senomyx, Inc. : August 14, 2017
finance.yahoo.com - August 15 at 7:07 AM |
| Senomyx, Inc. :SNMX-US: Earnings Analysis: Q2, 2017 By the Numbers : July 31, 2017
finance.yahoo.com - August 1 at 6:23 AM |
| Senomyx Announces Second Quarter 2017 Financial Results
finance.yahoo.com - July 28 at 8:03 AM |
| Edited Transcript of SNMX earnings conference call or presentation 27-Jul-17 9:00pm GMT
finance.yahoo.com - July 28 at 8:03 AM |
 | Senomyx, Inc. (NASDAQ:SNMX) Posts Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - July 27 at 9:20 PM |
 | Senomyx (SNMX) Announces Resignation of CFO, Tony Rogers
www.streetinsider.com - June 11 at 12:57 AM |
| ValuEngine Lowers Senomyx Inc. (SNMX) to Strong Sell
www.americanbankingnews.com - June 3 at 10:14 AM |
| Senomyx Confirms Previously Announced Results of 2017 Annual Meeting
finance.yahoo.com - May 22 at 6:58 PM |
| Senomyx Announces Results of 2017 Annual Meeting
finance.yahoo.com - May 17 at 7:51 PM |
 | Dissident Nominees for Senomyx Board of Directors Available Immediately for Phone Calls with Shareholders
www.businesswire.com - May 15 at 9:18 AM |
| Senomyx Inc. (SNMX) Upgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - May 14 at 6:28 PM |
| Roth Capital Reiterates $2.00 Price Target for Senomyx Inc. (SNMX)
www.americanbankingnews.com - May 4 at 1:09 AM |
| ETFs with exposure to Senomyx, Inc. : May 2, 2017
finance.yahoo.com - May 2 at 5:45 PM |
| ISS and Glass Lewis Recommend a Vote FOR ALL of Senomyx’s Nominees
finance.yahoo.com - May 2 at 9:21 AM |
| Senomyx (SNMX) Earning Positive Media Coverage, Study Finds
www.americanbankingnews.com - May 1 at 5:08 PM |
| Senomyx, Inc. :SNMX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017
finance.yahoo.com - May 1 at 11:45 AM |
| Senomyx Inc. (SNMX) Lowered to "Sell" at Zacks Investment Research
www.americanbankingnews.com - April 29 at 8:31 AM |
| Edited Transcript of SNMX earnings conference call or presentation 27-Apr-17 9:00pm GMT
finance.yahoo.com - April 29 at 5:55 AM |
| Senomyx (SNMX) Earns Daily News Impact Rating of 0.10
www.americanbankingnews.com - April 28 at 5:12 PM |
| Senomyx Inc. (SNMX) Posts Earnings Results, Hits Expectations
www.americanbankingnews.com - April 28 at 1:04 AM |
| Senomyx Inc. (SNMX) Posts Quarterly Earnings Results, Meets Expectations
www.americanbankingnews.com - April 27 at 11:16 PM |
| SENOMYX ANNOUNCES FIRST QUARTER 2017 FINANCIAL RESULTS
finance.yahoo.com - April 27 at 8:25 PM |
 | Senomyx reports 1Q loss
marketbeat.com - April 27 at 7:22 PM |
| Investor Network: Senomyx, Inc. to Host Earnings Call
finance.yahoo.com - April 27 at 3:24 PM |
| Senomyx (SNMX) Earning Favorable Press Coverage, Study Shows
www.americanbankingnews.com - April 24 at 5:28 PM |
| SENOMYX, INC. FIRST QUARTER 2017 EARNINGS CONFERENCE CALL SCHEDULED FOR APRIL 27, 2017
finance.yahoo.com - April 18 at 9:09 AM |
| Senomyx (SNMX) Earning Somewhat Positive Media Coverage, Report Shows
www.americanbankingnews.com - April 17 at 6:13 PM |
| SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 16TH ANNUAL NEEDHAM HEALTHCARE CONFERENCE
finance.yahoo.com - March 30 at 8:11 PM |
| Senomyx, Inc. Sends Letter to Shareholders
finance.yahoo.com - March 30 at 12:05 AM |
| 9:04 am Senomyx mails a letter to shareholders in connection with the Company's upcoming 2017 Annual Meeting of Shareholders to be held on May 11; the letter urges shareholders to vote FOR all seven of the Co's director nominees
finance.yahoo.com - March 30 at 12:05 AM |
| Analysts Anticipate Senomyx Inc. (SNMX) to Post ($0.07) Earnings Per Share
www.americanbankingnews.com - March 27 at 11:53 AM |
| Insider Buying: Senomyx Inc. (SNMX) CEO Acquires 50,000 Shares of Stock
www.americanbankingnews.com - March 23 at 10:34 PM |
| SENOMYX INC Financials
finance.yahoo.com - March 8 at 8:09 PM |
| SENOMYX INC Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - March 8 at 8:09 PM |
 | Earnings Reaction History: Senomyx Inc., 50.0% Follow-Through Indicator, 12.6% Sensitive - Nasdaq
www.nasdaq.com - March 4 at 12:57 AM |
| Edited Transcript of SNMX earnings conference call or presentation 2-Mar-17 10:00pm GMT
finance.yahoo.com - March 3 at 7:56 PM |
| Q4 2016 Senomyx Inc Earnings Release - After Market Close
us.rd.yahoo.com - March 2 at 8:00 PM |
 | SENOMYX ANNOUNCES FOURTH QUARTER AND FULL YEAR 2016 FINANCIAL RESULTS
us.rd.yahoo.com - March 2 at 8:00 PM |
| 4:19 pm Senomyx beats by $0.01, misses on revs; guides Q1 EPS above estimate, revs in-line
us.rd.yahoo.com - March 2 at 8:00 PM |
| SENOMYX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
us.rd.yahoo.com - March 2 at 8:00 PM |
| Senomyx Inc Earnings Call scheduled for 5:00 pm ET today
biz.yahoo.com - March 2 at 8:00 PM |
 | Senomyx, Inc. Fourth Quarter and Fiscal Year 2016 Earnings Conference Call Scheduled for March 2, 2017 - GlobeNewswire (press release)
www.globenewswire.com - February 25 at 3:29 AM |
| Senomyx, Inc. Fourth Quarter and Fiscal Year 2016 Earnings Conference Call Scheduled for March 2, 2
www.nasdaq.com - February 24 at 10:27 PM |
| Senomyx, Inc. Fourth Quarter and Fiscal Year 2016 Earnings Conference Call Scheduled for March 2, 2017
finance.yahoo.com - February 24 at 10:27 PM |
| SENOMYX INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
biz.yahoo.com - February 24 at 10:27 PM |
 | Technical Roundup on Specialty Chemicals Stocks -- Sherwin-Williams, TerraVia, Senomyx, and International Flavors ... - PR Newswire (press release)
www.prnewswire.com - February 4 at 1:57 AM |
| SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 19TH ANNUAL NEEDHAM GROWTH CONFERENCE
finance.yahoo.com - January 6 at 4:53 AM |
Senomyx (SNMX) Chart for Sunday, August, 20, 2017
